Overview
Rapid growth in the peptide market has drawn increasing attention from regulators, leaving providers, operators, and investors navigating a complex and evolving landscape. This webinar will examine where peptide regulation and enforcement are heading and what it means for clinical practice and investment in this space.
We will cover:
- Peptide fundamentals and classification: Overview of what peptides are, key terminology, and how they are defined and categorized.
- Regulatory landscape and gray areas: Political interest, FDA positioning, potential impacts of peptides being withdrawn from 503A category 2, and what this means for compounding and compliance.
- Medical practice considerations: Considerations for providers contemplating peptide therapy offerings, both in-person and virtually, how state laws and medical boards are responding, and key operational risks.
- Marketing, consent, and advertising risk: FTC considerations, performance claims, and areas of scrutiny in promotion and patient communications.
- Enforcement trends and investor takeaways: Recent warning letters, private labeling considerations, and what investors should evaluate when assessing opportunities in the peptide market.
Continuing Legal Education (CLE) credit is pending. McDermott Will & Schulte is an approved provider and can provide credit in California, Illinois, and New York. McDermott Will & Schulte is a sponsor and will apply for credit in Delaware, Florida, Georgia, Tennessee, Texas, and Virginia when lawyers licensed in these jurisdictions are in attendance. We can issue reciprocal credit for lawyers licensed in Connecticut and New Jersey. For all other jurisdictions not listed, attendees will be provided with a Universal Certificate of Attendance which they may use to self-apply for CLE credit in their state of admission. Attendees should contact their state’s CLE Board for current rules, regulations, and guidance.